These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32 related articles for article (PubMed ID: 34148210)
1. Herpetetrone nanosuspensions enhance drug solubility and bioavailability to improve anti-hepatic fibrosis effects. Zhong Y; Hang L; Wang F; Shen B; Shen C; Xue Y; Jia H; Wang L; Yuan H J Microencapsul; 2023 Dec; 40(8):587-598. PubMed ID: 37733492 [TBL] [Abstract][Full Text] [Related]
2. Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability. Rahim H; Sadiq A; Ullah R; Bari A; Amin F; Farooq U; Ullah Jan N; Mahmood HM Int J Nanomedicine; 2020; 15():8999-9009. PubMed ID: 33235448 [TBL] [Abstract][Full Text] [Related]
3. Preparation of Piroxicam nanosuspensions by high pressure homogenization and evaluation of improved bioavailability. Aksoy OA; Zanbak Çotaoğlu M; Fatsa T; Topal GR; Eşim Ö; Göksel BA; Hoşbul T; Özkan CK; Savaşer A; Özkan Y Drug Dev Ind Pharm; 2023 Dec; 49(12):715-722. PubMed ID: 38087641 [TBL] [Abstract][Full Text] [Related]
4. Nanocrystals of Mangiferin Using Design Expert: Preparation, Characterization, and Pharmacokinetic Evaluation. Sarwar AR; Iqbal FM; Jamil MA; Abbas K Molecules; 2023 Aug; 28(15):. PubMed ID: 37570887 [TBL] [Abstract][Full Text] [Related]
5. pH-driven entrapment of enrofloxacin in casein-based nanoparticles for the enhancement of oral bioavailability. Yuan ZX; Deng S; Chen L; Hu Y; Gu J; He L Food Sci Nutr; 2021 Aug; 9(8):4057-4067. PubMed ID: 34401057 [TBL] [Abstract][Full Text] [Related]
6. Research progress on the preparation and application of flavonoid nanocrystals. Tian Y; Shi Z; Ma H Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):338-348. PubMed ID: 37476945 [TBL] [Abstract][Full Text] [Related]
7. Preparation of Tetrandrine Nanocrystals by Microfluidic Method and Its In Vitro and In Vivo Evaluation. Huang J; Huang S; Liu S; Feng L; Huang W; Wang Y; Huang D; Huang T; Huang X AAPS PharmSciTech; 2023 Dec; 25(1):4. PubMed ID: 38114843 [TBL] [Abstract][Full Text] [Related]
8. Long-term antitrypanosomal effect of quinapyramine sulphate-loaded oil-based nanosuspension in T. evansi-infected mouse model. Prayag KS; Paul AT; Ghorui SK; Jindal AB Drug Deliv Transl Res; 2024 Feb; 14(2):542-554. PubMed ID: 37648938 [TBL] [Abstract][Full Text] [Related]
9. Controlled preparation of curcumin nanocrystals by detachable stainless steel microfluidic chip. Zheng X; Zhang J; Zhang L; Huangfu X; Li Y; Chen J Int J Pharm; 2024 Sep; 663():124574. PubMed ID: 39134290 [TBL] [Abstract][Full Text] [Related]
10. Nanocrystal Suspensions for Enhancing the Oral Absorption of Albendazole. Liang Z; Chen M; Yan Y; Chen D; Xie S Nanomaterials (Basel); 2022 Sep; 12(17):. PubMed ID: 36080069 [TBL] [Abstract][Full Text] [Related]
11. Drug delivery for fighting infectious diseases: a global perspective. Loretz B; Oh YK; Hudson S; Gu Z; Lehr CM Drug Deliv Transl Res; 2021 Aug; 11(4):1316-1322. PubMed ID: 34109534 [No Abstract] [Full Text] [Related]
12. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability. Jain S; Reddy VA; Arora S; Patel K Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488 [TBL] [Abstract][Full Text] [Related]
13. Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation. Wang Y; Wang S; Xu Y; Wang P; Li S; Liu L; Liu M; Jin X Int J Nanomedicine; 2020; 15():7601-7613. PubMed ID: 33116490 [TBL] [Abstract][Full Text] [Related]
14. Fabrication of Ibrutinib Nanosuspension by Quality by Design Approach: Intended for Enhanced Oral Bioavailability and Diminished Fast Fed Variability. Rangaraj N; Pailla SR; Chowta P; Sampathi S AAPS PharmSciTech; 2019 Oct; 20(8):326. PubMed ID: 31659558 [TBL] [Abstract][Full Text] [Related]
15. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension. Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182 [TBL] [Abstract][Full Text] [Related]
16. Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs. Elsebay MT; Eissa NG; Balata GF; Kamal MA; Elnahas HM Curr Pharm Des; 2023; 29(29):2297-2312. PubMed ID: 37694786 [TBL] [Abstract][Full Text] [Related]
17. Exploitation of nanocrystal suspension as an effective oral formulation for oxfendazole. Sun Y; Chen D; Zhao Y; Zhou K; Zhang B; Wang H; Xie S Drug Deliv Transl Res; 2022 May; 12(5):1219-1229. PubMed ID: 34148210 [TBL] [Abstract][Full Text] [Related]